Literature DB >> 17408930

Diffusion tensor imaging in dementia with Lewy bodies and Alzheimer's disease.

Michael J Firbank1, Andrew M Blamire, Mani S Krishnan, Andrew Teodorczuk, Philip English, Anil Gholkar, Roger M Harrison, John T O'Brien.   

Abstract

Dementia with Lewy bodies (DLB) is a common form of dementia, with fewer memory deficits, and more visuo-perceptual problems than Alzheimer's disease (AD). We hypothesized that there would be disease specific alterations revealed by diffusion tensor imaging with AD showing temporal lobe and DLB more parietal changes. We recruited 15 people with AD, 16 with DLB, and 15 healthy control subjects of similar age. They were scanned on a 1.5 T MRI system with diffusion tensor FLAIR imaging. Apparent diffusion coefficient (ADC) and fractional anisotropy (FA) maps were calculated, and data were analysed using pre-defined regions of interest (ROI) and also with SPM. We found a significant decrease in the FA map in a ROI in the parietal lobe (precuneus) of the DLB group. Using SPM we found increased ADC in the left temporal lobe of AD subjects compared to controls. There were no other significant differences between groups. We conclude that there are subtle changes visible with diffusion imaging in DLB and AD which may reflect disrupted connectivity and underlie observed perfusion changes in these disorders.

Entities:  

Mesh:

Year:  2007        PMID: 17408930     DOI: 10.1016/j.pscychresns.2007.01.001

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  27 in total

1.  Measurement of gray and white matter atrophy in dementia with Lewy bodies using diffeomorphic anatomic registration through exponentiated lie algebra: A comparison with conventional voxel-based morphometry.

Authors:  R Takahashi; K Ishii; N Miyamoto; T Yoshikawa; K Shimada; S Ohkawa; T Kakigi; K Yokoyama
Journal:  AJNR Am J Neuroradiol       Date:  2010-07-15       Impact factor: 3.825

Review 2.  Neuroimaging and cognition in Parkinson's disease dementia.

Authors:  Lisa C Silbert; Jeffrey Kaye
Journal:  Brain Pathol       Date:  2010-05       Impact factor: 6.508

Review 3.  Imaging of the dopaminergic system in differential diagnosis of dementia.

Authors:  Klaus Tatsch
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-03       Impact factor: 9.236

Review 4.  Diffusion tensor imaging in parkinsonian syndromes: a systematic review and meta-analysis.

Authors:  Claire J Cochrane; Klaus P Ebmeier
Journal:  Neurology       Date:  2013-02-26       Impact factor: 9.910

Review 5.  The role of functional dopamine-transporter SPECT imaging in parkinsonian syndromes, part 2.

Authors:  T C Booth; M Nathan; A D Waldman; A-M Quigley; A H Schapira; J Buscombe
Journal:  AJNR Am J Neuroradiol       Date:  2014-06-12       Impact factor: 3.825

6.  Characterizing dementia with Lewy bodies by means of diffusion tensor imaging.

Authors:  Rosie Watson; Andrew M Blamire; Sean J Colloby; Josh S Wood; Robert Barber; Jiabao He; John T O'Brien
Journal:  Neurology       Date:  2012-08-15       Impact factor: 9.910

7.  Triple-transgenic Alzheimer's disease mice exhibit region-specific abnormalities in brain myelination patterns prior to appearance of amyloid and tau pathology.

Authors:  Maya K Desai; Kelly L Sudol; Michelle C Janelsins; Michael A Mastrangelo; Maria E Frazer; William J Bowers
Journal:  Glia       Date:  2009-01-01       Impact factor: 7.452

Review 8.  Current and future uses of neuroimaging for cognitively impaired patients.

Authors:  Gary W Small; Susan Y Bookheimer; Paul M Thompson; Greg M Cole; S-C Huang; Vladimir Kepe; Jorge R Barrio
Journal:  Lancet Neurol       Date:  2008-02       Impact factor: 44.182

9.  Imaging improves diagnosis of dementia with lewy bodies.

Authors:  Masaru Tateno; Seiju Kobayashi; Toshikazu Saito
Journal:  Psychiatry Investig       Date:  2009-11-21       Impact factor: 2.505

10.  Imaging informatics for personalised medicine: applications and challenges.

Authors:  Tianming Liu; Hanchuan Peng; Xiaobo Zhou
Journal:  Int J Funct Inform Personal Med       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.